Ask AI
ProCE Banner Activity

The Promise of B7-H3 ADCs in Small-Cell Lung Cancer

Clinical Thought

Read this expert commentary to stay current with the latest evidence on antibody–drug conjugates targeting B7-H3 in small-cell lung cancer.

Released: July 21, 2025

Expiration: January 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.

Disclosure

Primary Author

Lauren Byers, MD: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Genentech, Jazz, Novartis, Puma.

Christine L. Hann, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Daiichi Sankyo, Genentech; researcher (paid to institution): AbbVie, Amgen, AstraZeneca, Daiichi Sankyo.